Stock 3320 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus China Resources Pharmaceutical Group Limited

Equities

3320

HK0000311099

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 am EDT 		5-day change 1st Jan Change
5.09 HKD +0.99% Intraday chart for China Resources Pharmaceutical Group Limited +5.17% -0.78%
Apr. 24 China Resources Pharmaceutical Group Limited Announces Change of Company Secretary CI
Apr. 18 China Resources Pharma Unit Issues 3 Billion Yuan Bonds MT

Evolution of the average Target Price on China Resources Pharmaceutical Group Limited

Price target over the last 5 years

History of analyst recommendation changes

32ac57ec765be2f34d33.M-7LYkqs7bxaiNHsjini28_VxJouRDu8acu_bNopQUw.S72sFzrPgY5s2ZjU1GuRnoeMk6NANVTkW4r3HZx-JH4EpLtQCeOA9RfNmA~ef5d76925f6fa0a1b15c2e1ffec76aee

Analyst Recommendations on China Resources Pharmaceutical Group Limited

Nomura Adjusts CR Pharmaceutical Group’s Price Target to HK$8.80 From HK$9.08, Keeps at Buy MT
Nomura Adjusts China Resources Pharmaceutical Group's Price Target to HK$9.08 From HK$9.32, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
5.09 HKD
Average target price
7.406 HKD
Spread / Average Target
+45.49%
High Price Target
9.3 HKD
Spread / Highest target
+82.71%
Low Price Target
5.82 HKD
Spread / Lowest Target
+14.34%

Consensus detail

Consensus revision (last 18 months)

Analysts covering China Resources Pharmaceutical Group Limited

Nomura

Ratings for China Resources Pharmaceutical Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 3320 Stock
  4. Consensus China Resources Pharmaceutical Group Limited